Abstract
Overview
Introduction
This analysis examines the historical and forecast performance for Astellas in the ethical pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sales forecasts for key drugs. An interactive forecasting and analysis tool provides continually updated quantitative and qualitative information.
Key reasons to read this report
- Benchmark Astellas' s performance against key rivals in the ethical pharmaceutical sector
- Evaluate Astellas' s product mix, with growth drivers positioned across all of its major therapeutic franchises
- See how the company will target the US market to drive growth as its position in Japan comes under pressure from increasing generic competition
View Cart
